share_log

Positive Earnings Growth Hasn't Been Enough to Get Dirui IndustrialLtd (SZSE:300396) Shareholders a Favorable Return Over the Last Year

Positive Earnings Growth Hasn't Been Enough to Get Dirui IndustrialLtd (SZSE:300396) Shareholders a Favorable Return Over the Last Year

正向的盈利增长并不足以让迪瑞工业股份有限公司(SZSE:300396)股东在过去一年中获得良好的回报。
Simply Wall St ·  08/06 19:51

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you buy individual stocks, you can make higher profits, but you also face the risk of under-performance. That downside risk was realized by Dirui Industrial Co.,Ltd. (SZSE:300396) shareholders over the last year, as the share price declined 29%. That contrasts poorly with the market decline of 20%. At least the damage isn't so bad if you look at the last three years, since the stock is down 11% in that time. In the last ninety days we've seen the share price slide 35%.

passive investing在指数基金中是一个很好的办法,可以确保你的回报大约与整个市场相匹配。当你购买个别股票时,你可以赚取更高的利润,但也面临着低于市场表现的风险。在过去一年中,迪瑞医疗股份有限公司的股东们经历了这种下行风险,因为股价下降了29%。与市场下降20%相比,这种对比非常糟糕。至少在看过去三年的表现后,损失还算不那么严重,因为在这段时间内股票下跌了11%。在过去的90天中,我们看到股价下跌了35%。

On a more encouraging note the company has added CN¥374m to its market cap in just the last 7 days, so let's see if we can determine what's driven the one-year loss for shareholders.

更令人鼓舞的是,迪瑞医疗股份有限公司在过去7天中已经为市值增加了人民币37400万元,所以让我们看看是什么推动了股东们的一年亏损。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

不可否认的是,市场有时是高效的,但价格并不总是反映潜在的商业表现。一个不完美但简单的方法来考虑公司市场感知如何改变是比较每股收益(EPS)变化和股价变动。

Even though the Dirui IndustrialLtd share price is down over the year, its EPS actually improved. Of course, the situation might betray previous over-optimism about growth.

尽管迪瑞医疗股份有限公司的股价一年来下跌了,但它的每股收益实际上有所提高。当然,这种情况可能背叛了对增长过度乐观的先前预测。

It's surprising to see the share price fall so much, despite the improved EPS. So it's easy to justify a look at some other metrics.

尽管EPS有所改善,股价下跌了这么多令人惊讶。因此,可以轻易地理解对其他一些指标进行研究的理由。

Dirui IndustrialLtd's revenue is actually up 29% over the last year. Since the fundamental metrics don't readily explain the share price drop, there might be an opportunity if the market has overreacted.

迪瑞医疗股份有限公司的营业收入实际上在过去一年中增长了29%。由于基本指标不容易解释股价下跌,所以如果市场反应过度,就可能存在机会。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

你可以在下面的图片中看到收入和营业收入随时间的变化情况(单击图表可查看精确值)。

big
SZSE:300396 Earnings and Revenue Growth August 6th 2024
SZSE:300396 2024年8月6日的营收和收益增长

We know that Dirui IndustrialLtd has improved its bottom line lately, but what does the future have in store? This free report showing analyst forecasts should help you form a view on Dirui IndustrialLtd

我们知道迪瑞医疗股份有限公司的底线近年来有所提高,但未来会有什么展望?这份免费的报告展示分析师的预测,应该有助于你对迪瑞医疗股份有限公司形成看法。

A Different Perspective

不同的观点

While the broader market lost about 20% in the twelve months, Dirui IndustrialLtd shareholders did even worse, losing 27% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Longer term investors wouldn't be so upset, since they would have made 3%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Dirui IndustrialLtd you should know about.

尽管广义市场在12个月中损失了约20%,但迪瑞医疗股份有限公司的股东们的亏损更大,下降了27%(即使包括分红)。然而,可能只是股价受到广义市场的恐慌影响。如果有好的机会,监视基本面可能很值得。长期的投资者不会那么沮丧,因为他们每年可以获得3%的回报,长达五年。最近的抛售可能是一个机会,所以检查基本数据是否表明长期增长趋势可能是值得的。虽然考虑市场条件可能对股价产生的不同影响非常重要,但还有其他更重要的因素。考虑风险,比如。每家公司都有它们自己的风险,我们已经发现了你应该知道的1个迪瑞医疗股份有限公司的警告信号。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

当然,您可能在其他地方找到一家出色的企业进行投资。因此,请查看我们预计将实现盈利增长的公司的免费列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所上市的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发